4. The Curious Case of the Adenoviral Vector Vaccines
Listen now
Description
Adenoviral vector vaccines are seen as the vaccine for the world given that they are cheaper to produce and easier to distribute versus mRNA vaccines. We learn about their development in the lab and challenges that have been overcome, while experts discuss possible roadblocks of pre-existing immunity that may impact future efficacy. While AstraZeneca's confusing interim results get dissected, experts look ahead to results from Johnson & Johnson's single shot vaccine, which could be a pandemic game changer if successful. Finally, experts discuss the safety of these vaccines especially after both AstraZeneca and Johnson & Johnson’s trials had to be paused for safety last year.
Guest profiles and timestamps available at https://thecovaxfiles.com
More Episodes
Published 12/01/21
Nearly two years after Covid-19 was first detected in Wuhan, the world is still very much in a pandemic. The toughest phase may behind us, but we are still faced with the possibility of new variants of concern, waning immunity and vaccine evasion. As first-generation vaccines start to show their...
Published 12/01/21
As the world tries to take a hold over the delta variant, we're all watching and waiting to see if the virus is going to evolve into something new. There are fears that natural selection could potentially yield a new variant that will completely escape all of our current vaccines. While these...
Published 11/24/21
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
